Cell-Penetrating Aptamers Targeting Sub-Cellular Compartments

靶向亚细胞区室的细胞穿透适体

基本信息

  • 批准号:
    9764414
  • 负责人:
  • 金额:
    $ 29.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

Cell-penetrating aptamers targeting sub-cellular compartments ABSTRACT: An unmet need in modern nanomedicine is a method for efficient delivery of nucleic acids and related cargo into relevant sub-cellular compartments in living tissues. Upon exposure of cells to nucleic acids or nucleic acid/cationic lipid complexes, conventional methods result in uptake into membrane- bound vesicles (still topologically outside of the cell) or indiscriminate membrane fusion. Moreover, many carrier lipid formulations are toxic and of limited use in vivo. While the power of in vitro selection (SELEX) has been previously applied to select nucleic acid sequences that bind cells or gain preferential vesicular uptake into specific cells or tissues, vesicular escape with intracellular targeting has not been envisioned. We have developed a novel approach to this goal. We apply in vitro selection to identify nucleic acid aptamers that efficiently enter specific sub-cellular compartments by selecting for sequences that undergo enzymatic modification dependent on specific intracellular enzyme activities. We show that this "reward" approach can identify naked DNA aptamers with substantially improved delivery to the cell nucleus (“karyophilic” aptamers). The method will be extended to identify cell-penetrating aptamers specific for different tissues in living mice. Rewarding aptamer sequences capable of vesicle escape and sub-cellular compartment delivery opens a new field of opportunities. In the future it may be possible to extend this reward approach to identify sequences that target other sub-cellular compartments. Four specific aims are proposed to test the hypotheses that cell-penetrating DNA aptamers targeting specific sub-cellular compartments can be identified by selecting molecules modified by organelle-specific enzyme activities, and that such homing aptamers can efficiently deliver cargo to cells and tissues. Aim 1 will continue our selection of karyophilic (nucleus- homing) DNA aptamers, setting the stage for the targeting of other sub-cellular compartments. Aim 2 will seek to understand the mechanism of nuclear delivery of karyophilic DNA aptamers. Aim 3 will explore the ability of karyophilic DNA aptamers to direct cargo delivery into cells. Aim 4 will extend this reward approach in vivo to develop a library of tissue-specific karyophilic DNA aptamers in mice.
靶向亚细胞区室的细胞穿透适体 摘要:现代纳米医学的一个未满足的需求是有效递送核酸的方法 以及相关的货物进入活组织中的相关亚细胞区室。当细胞暴露于 核酸或核酸/阳离子脂质复合物,常规方法导致摄取到膜中, 结合的囊泡(仍然拓扑地在细胞外)或不加选择的膜融合。而且很多 载体脂质制剂是有毒的并且在体内的使用有限。虽然体外选择的力量(SELEX) 先前被应用于选择结合细胞或获得优先囊泡摄取的核酸序列 进入特定的细胞或组织,尚未设想具有细胞内靶向的囊泡逃逸。我们有 开发了一种新的方法来实现这一目标。我们应用体外选择来鉴定核酸适体, 有效地进入特定的亚细胞区室通过选择的序列, 依赖于特定细胞内酶活性的修饰。我们发现这种“奖励”方法 可以鉴定出具有显著改善的细胞核递送的裸DNA适体(“亲核的 适体)。该方法将被扩展到识别不同组织的细胞穿透适体, 活老鼠能够囊泡逃逸和亚细胞区室递送的奖励适体序列 开辟了一个新的机会领域。在未来,也许有可能扩展这种奖励方法,以确定 靶向其他亚细胞区室的序列。提出了四个具体目标来检验假设 靶向特定亚细胞区室的细胞穿透DNA适体可以通过以下方式艾德: 选择由细胞器特异性酶活性修饰的艾德分子,并且这种归巢适体 可以有效地将货物运送到细胞和组织。目的1将继续我们的选择嗜核(核- 归巢)DNA适体,为靶向其他亚细胞区室奠定基础。目标2将寻求 了解嗜核DNA适体的核传递机制。目标3将探索 亲核DNA适体以引导货物递送到细胞中。目标4将在体内扩展这种奖励方法, 在小鼠中开发组织特异性嗜核DNA适体文库。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LOUIS JAMES MAHER其他文献

LOUIS JAMES MAHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LOUIS JAMES MAHER', 18)}}的其他基金

In vivo SELEX strategies to identify potent aptamer-drug conjugates for glioblastoma
体内 SELEX 策略鉴定针对胶质母细胞瘤的有效适体-药物缀合物
  • 批准号:
    10721036
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
Genome-wide synthetic lethal screening for vulnerabilities in a cell model of succinate dehydrogenase-loss paraganglioma
全基因组合成致死筛查琥珀酸脱氢酶缺失副神经节瘤细胞模型中的漏洞
  • 批准号:
    10572019
  • 财政年份:
    2022
  • 资助金额:
    $ 29.44万
  • 项目类别:
Fundamental and applied studies of nucleic acids
核酸的基础与应用研究
  • 批准号:
    10323099
  • 财政年份:
    2022
  • 资助金额:
    $ 29.44万
  • 项目类别:
Fundamental and applied studies of nucleic acids
核酸的基础与应用研究
  • 批准号:
    10557080
  • 财政年份:
    2022
  • 资助金额:
    $ 29.44万
  • 项目类别:
Molecular Basis of Familial Paraganglioma
家族性副神经节瘤的分子基础
  • 批准号:
    8691748
  • 财政年份:
    2013
  • 资助金额:
    $ 29.44万
  • 项目类别:
Molecular Basis of Familial Paraganglioma
家族性副神经节瘤的分子基础
  • 批准号:
    8574656
  • 财政年份:
    2013
  • 资助金额:
    $ 29.44万
  • 项目类别:
Molecular Basis of Familial Paraganglioma
家族性副神经节瘤的分子基础
  • 批准号:
    9248912
  • 财政年份:
    2013
  • 资助金额:
    $ 29.44万
  • 项目类别:
Molecular Basis of Familial Paraganglioma
家族性副神经节瘤的分子基础
  • 批准号:
    8841328
  • 财政年份:
    2013
  • 资助金额:
    $ 29.44万
  • 项目类别:
Molecular Basis of Familial Paraganglioma
家族性副神经节瘤的分子基础
  • 批准号:
    9057471
  • 财政年份:
    2013
  • 资助金额:
    $ 29.44万
  • 项目类别:
Post-baccalaureate Training in Biomedical Research
生物医学研究学士后培训
  • 批准号:
    7882211
  • 财政年份:
    2009
  • 资助金额:
    $ 29.44万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 29.44万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
  • 批准号:
    23KK0126
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 29.44万
  • 项目类别:
    Training Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了